Mode
Text Size
Log in / Sign up

Evaluating the Impact of Digital Health Interventions on Chronic Disease Self-Care OutcomesDigital health tools show mixed results for managing chronic diseases

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Digital interventions improve heart failure monitoring but show inconsistent results for medication adherence.

This systematic review and meta-analysis evaluates the efficacy of digital health interventions—including mobile applications, telemonitoring, connected devices, and text-messaging—across a diverse cohort of 5,889 adults managing chronic conditions such as diabetes, heart failure, hypertension, and COPD. The primary objective was to determine if these technological tools could improve self-care behaviors, specifically focusing on monitoring activities and medication adherence.

The findings indicate significant heterogeneity in outcomes across different conditions. For patients with heart failure, digital interventions demonstrated a statistically significant improvement in self-care monitoring (SMD=0.49; 95% CI 0.13-0.85). This suggests that remote monitoring and connected devices may be particularly effective for tracking physiological parameters or specific management protocols in cardiac patients.

In contrast, the results for diabetes management were largely inconclusive. Despite the wide range of interventions tested—including diet, exercise, and glucose monitoring support—there was little to no clear improvement in overall self-care behaviors for diabetic patients. This suggests that digital tools alone may not be sufficient to drive complex behavioral changes without integrated clinical oversight.

Regarding medication adherence, the meta-analysis found no significant overall improvement across the studied conditions (SMD=0.06; 95% CI -0.31 to 0.42). The evidence for this specific outcome was of very low certainty, likely due to methodological inconsistencies and varied intervention designs in the primary studies included.

Several limitations impacted the strength of these conclusions. Methodological heterogeneity, small sample sizes in certain sub-groups, and short follow-up periods limited the ability to draw definitive conclusions for many conditions. Furthermore, the GRADE assessment indicated that much of the evidence was of low or very low certainty.

For healthcare providers, these findings suggest a nuanced approach to digital health integration. While digital tools are highly promising for enhancing monitoring capabilities in specific contexts like heart failure, they should not be viewed as a universal solution for improving medication adherence or general lifestyle modifications in chronic disease management. Clinical practice should focus on targeted applications where data suggests the highest potential for patient benefit.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in the evaluation of digital health interventions for chronic disease management. While previous evidence suggests that pharmacist-led telepharmacy may improve medication adherence in patients with NCDs, this meta-analysis indicates that general digital health interventions (mobile apps, telemonitoring) show little to no overall improvement in medication adherence (SMD 0.06; 95% CI -0.31 to 0.42).

Living with a chronic condition like heart failure or diabetes is often a daily marathon. Patients must manage complex medications, monitor symptoms, and make constant lifestyle choices to stay healthy. Because of this, many people turn to digital tools—such as mobile apps, text message reminders, and connected devices—to help them keep track of their health goals. This research looked at whether these technologies actually help patients manage their conditions better.

Researchers analyzed data from 5,889 adults living with various long-term illnesses, including heart failure, diabetes, and hypertension. They specifically looked at how digital tools affected self-care behaviors, such as monitoring symptoms and sticking to medication schedules. This type of review is important because it looks at many different studies at once to see if there is a clear pattern in what works.

The results were mixed. For people living with heart failure, the data showed that digital tools likely helped them monitor their condition more effectively. However, for other conditions like diabetes, the study found little to no clear improvement in general self-care behaviors, such as diet or exercise. Perhaps most importantly, the researchers found that these digital tools did not show a significant overall improvement in helping patients stay on track with their medications across the different conditions studied.

It is important to keep these findings in perspective. The evidence for many of these results was considered low or very low certainty by the researchers. This means the data might be inconsistent because the individual studies were small, had short follow-up periods, or used different ways to measure success. Because of these limitations, we cannot say that a specific app will definitely work for every patient.

What does this mean for you right now? If you have heart failure, digital tools might be a helpful way to monitor your symptoms daily. However, if you are looking for an app to ensure you never miss a pill or to completely overhaul your diet for diabetes, the evidence is not yet strong enough to guarantee success. For now, these tools are best used as one part of a larger care plan rather than a total solution for managing medications or lifestyle changes.

What this means for you:
Digital tools may help heart failure patients monitor symptoms, but they show little impact on medication habits.

Study Details

Study typeMeta analysis
Sample sizen = 5,889
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BACKGROUND: Chronic diseases account for most global morbidity and mortality, increasing the need for effective long-term self-care support. Digital health interventions, such as mobile apps, telemonitoring, and connected devices, are increasingly used to promote self-care; yet, their overall effectiveness across chronic conditions remains unclear. OBJECTIVE: This systematic review and meta-analysis evaluated whether digital health interventions improve self-care in adults with chronic diseases. METHODS: We searched PubMed, CINAHL, Scopus, and PsycINFO for randomized controlled trials (RCTs; January 1, 2013, to December 31, 2025) that assessed digital health interventions targeting self-care outcomes, as measured with validated instruments, in patients with chronic conditions. Standardized mean differences (SMDs) were pooled using random-effects models, while results not suitable for meta-analysis were synthesized narratively. Risk of bias was assessed with the Cochrane Risk of Bias 2.0 tool for RCTs and certainty of evidence with Grading of Recommendations Assessment, Development and Evaluation. RESULTS: A total of 55 RCTs involving 5889 participants were included. Most interventions were multicomponent and mainly based on mobile or web-based applications, telemonitoring, connected devices, and text-messaging support. In diabetes, pooled analyses showed little to no clear improvement across self-care domains measured with the Summary of Diabetes Self-Care Activities, including general diet (3 studies), specific diet (3 studies), exercise (5 studies), foot care (5 studies), and glucose monitoring (4 studies), with low to very low certainty of evidence. In heart failure, digital interventions probably improved self-care monitoring measured with the Self-Care of Heart Failure Index (5 studies, 364 participants; SMD=0.49, 95% CI 0.13-0.85; low certainty), whereas effects on self-care maintenance (5 studies) and on self-care measured with the European Heart Failure Self-Care Behaviour Scale (3 studies) were not clearly demonstrated. In other chronic conditions, narrative synthesis suggested possible benefits in some cardiovascular conditions, chronic hepatitis B, epilepsy, and hypertension, while no significant effects were found in chronic obstructive pulmonary disease and multimorbidity, and mixed findings emerged in Parkinson disease. Across 17 studies, medication adherence showed little to no overall improvement (SMD=0.06, 95% CI -0.31 to 0.42, 95% prediction interval -0.98 to 1.09; very low certainty), indicating that future studies could plausibly show either benefit or no effect. Overall, heterogeneity was substantial, and most evidence was of low or very low certainty. CONCLUSIONS: This review is innovative in providing an up-to-date, cross-condition synthesis focused specifically on self-care as a multidimensional outcome, rather than on clinical end points alone or single diseases. The findings suggest that digital health interventions may be more effective for supporting self-care monitoring than for promoting broader behavioral maintenance or medication adherence. Evidence is limited by methodological heterogeneity, small sample sizes, short follow-up periods, and varied outcome measures. Larger designed trials using standardized self-care metrics and equity-focused approaches are needed to clarify effectiveness and guide implementation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.